发展pH选择性PD-1/PD-L1信号通路抑制在抗癌的计算方法
相关实验视频
Updated: Jun 21, 2025

07:04
Identifying PD-1/PD-L1 Inhibitors with Surface Plasmon Resonance Technology
Published on: May 2, 2025
281
Roderick C McDowell1, Jordhan D Booth2, Allyson McGowan2
1Department of Chemistry, Physics and Atmospheric Sciences, Jackson State University, Jackson, MS 39217, USA.
Cancers
|July 13, 2024
概括
研究人员发现了一种新型的pH选择性抑制剂,向瘤中的PD-1/PD-L1通路. 这种方法旨在提高癌症免疫治疗的精度,并通过向酸性瘤微环境来减少副作用.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 计算化学计算化学
背景情况:
- 针对PD-1/PD-L1通路的免疫疗法在癌症治疗中显示出前景.
- 然而,针对健康细胞的非特异性免疫激活仍然是一个重大挑战.
- 瘤微环境通常表现出酸性pH值,与健康组织不同.
研究的目的:
- 为在酸性瘤微环境中选择性PD-L1通路向制定战略.
- 使用in silico方法识别新的pH选择性抑制剂.
- 为了减少与当前免疫疗法相关的非目标毒性.
主要方法:
- 从MolPort数据库中对大约1万种天然化合物的虚拟选.
- 在生理 (pH 7.4) 和酸性 (pH 5.5) 条件下的分子力学和分子动力学模拟.
- 对抑制剂结合亲和力和复合稳定性的分析.
主要成果:
- 化合物MolPort-001-742-690显示出有希望的pH选择性抑制PD-L1.
- 这种抑制剂在酸性条件下与中性pH相比,对PD-L1表现出更高的亲和力.
- 分子动力学模拟证实了在酸性pH下抑制剂-PD-L1复合物的稳定性,预测毒性低于现有抑制剂.
结论:
- 在基技术可以有效地发现针对癌症免疫治疗的pH选择性抑制剂.
- MolPort-001-742-690代表了提高免疫治疗精度和安全性的潜在候选人.
- 需要进一步的实验验证,以将这些发现转化为临床应用.
相关概念视频
Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
Interactions Between Signaling Pathways
6.3K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.3K

